Your browser doesn't support javascript.
loading
SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse.
Qian, Feng-Cui; Zhou, Li-Wei; Li, Yan-Yu; Yu, Zheng-Min; Li, Li-Dong; Wang, Yue-Zhu; Xu, Ming-Cong; Wang, Qiu-Yu; Li, Chun-Quan.
Afiliação
  • Qian FC; The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
  • Zhou LW; The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
  • Li YY; National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan 410008, China.
  • Yu ZM; School of Computer, University of South China, Hengyang, Hunan 421001, China.
  • Li LD; Insititute of Biochemistry and Molecular Biology, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China.
  • Wang YZ; The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, China.
  • Xu MC; School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China.
  • Wang QY; School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China.
  • Li CQ; The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Nucleic Acids Res ; 51(W1): W520-W527, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37194711
Super-enhancers (SEs) play an essential regulatory role in various biological processes and diseases through their specific interaction with transcription factors (TFs). Here, we present the release of SEanalysis 2.0 (http://licpathway.net/SEanalysis), an updated version of the SEanalysis web server for the comprehensive analyses of transcriptional regulatory networks formed by SEs, pathways, TFs, and genes. The current version added mouse SEs and further expanded the scale of human SEs, documenting 1 167 518 human SEs from 1739 samples and 550 226 mouse SEs from 931 samples. The SE-related samples in SEanalysis 2.0 were more than five times that in version 1.0, which significantly improved the ability of original SE-related network analyses ('pathway downstream analysis', 'upstream regulatory analysis' and 'genomic region annotation') for understanding context-specific gene regulation. Furthermore, we designed two novel analysis models, 'TF regulatory analysis' and 'Sample comparative analysis' for supporting more comprehensive analyses of SE regulatory networks driven by TFs. Further, the risk SNPs were annotated to the SE regions to provide potential SE-related disease/trait information. Hence, we believe that SEanalysis 2.0 has significantly expanded the data and analytical capabilities of SEs, which helps researchers in an in-depth understanding of the regulatory mechanisms of SEs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Software / Elementos Facilitadores Genéticos / Redes Reguladoras de Genes Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Software / Elementos Facilitadores Genéticos / Redes Reguladoras de Genes Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China